Document:

Letter Agreement

 Exhibit 10.1 
 Nationwide Health Properties, Inc. 
 610 Newport Center Drive, Suite 1150 
 Newport Beach, CA 92660 
 February 22, 2008 

David E. Snyder 
 c/o Nationwide Health Properties, Inc. 
 610 Newport Center Drive, Suite 1150 
 Newport Beach, CA 92660 
 Dear David: 
 This letter will confirm our mutual agreement with respect to
the following terms and conditions applicable to (i) your resignations as Vice President and Controller of Nationwide Health Properties, Inc. (the “Company”) and as an officer of the Company, and any of its subsidiaries, and
(ii) your employment as a non-officer employee of the Company, in each case, and effective February 29, 2008. 
  

			
	Term of Employment:	  	You will be employed as a non-officer employee of the Company beginning February 29, 2008 until termination of your employment.
		
	Duties:	  	You will report to the Senior Vice President and Chief Financial and Portfolio Officer and will devote your full working time (exclusive of vacations) to the performance of such duties as
assigned by the Senior Vice President and Chief Financial and Portfolio Officer. You will be given time prior to May 30, 2008 to use all of your accrued vacation time.
		
	Bonus:	  	Subject to the approval of the Compensation Committee of the Company’s Board of Directors, you will be paid a bonus of $55,000, payable in two equal installments. The first installment
shall be payable on February 29, 2008. The second installment shall be payable following your termination of employment with the Company, other than a termination by the Company for “Cause”, that occurs on or after April 18, 2008, and
shall be prorated based on the number of days employed between March 1, 2008 and May 30, 2008. The payment of the second installment is

			
		  	conditioned upon your execution and delivery to the Company of a Release of Claims substantially in the form attached hereto as Exhibit A within five business days following termination of
employment. For purposes of this letter, “Cause” shall have the meaning set forth in your Change in Control Agreement.
		
	 Salary, Health Insurance
 And Other
Benefits:
	  	Salary, health insurance (including your participation in the Company’s executive health care program) and other benefits to remain as current, subject to the terms of the individual
plans and as modified from time to time by the Company under its general employment policies.
		
	General:	  	Except as otherwise set forth in this letter, (i) the terms and conditions applicable to your employment will continue to be subject to the terms and conditions of applicable plans and
policies of the Company generally applicable to its employees, (ii) the terms and conditions of your equity awards will continue to be subject to the terms and conditions of applicable plans and agreements and (iii) your Change in Control Agreement
will continue to apply in accordance with its terms. Your employment will continue on an at-will basis and can be terminated by you or the Company at any time, for any reason, with or without cause, with or without advance notice. Except as provided
above, this letter constitutes the entire agreement between the parties and supersedes any and all prior agreements or understandings of the parties as to the matters set forth herein; provided that no existing arrangements that are to be terminated
or modified as described herein shall be so affected except in accordance with definitive documentation affecting the matters described herein.

 Please date, sign and return one original of this letter. 
  

	
	 Sincerely,

	
	 /s/ Douglas M. Pasquale

	 Douglas M. Pasquale
 President and Chief Executive Officer

 By my signature below I acknowledge that I have read the terms of this agreement and accept the terms stated above.

  

									
	 /s/ David Snyder
	 		 	 2/22/08
	 		 	
	David Snyder	 		 	Date	 		 	

 Exhibit A 
 WAIVER AND GENERAL RELEASE OF ALL CLAIMS 
 1. WAIVER AND RELEASE OF ALL CLAIMS. 
 a. In consideration of the payment of the bonus in the amount of $55,000 (the “Bonus”), David E. Snyder (“Employee”) Employee hereby
forever releases and discharges Nationwide Health Properties, Inc. (the “Company”), its affiliates, successors and assigns, as well as each of its past and present officers, directors, employees, agents, attorneys and shareholders
(collectively, the “Released Parties”), from any and all claims, charges, complaints, liens, demands, causes of action, obligations, damages and liabilities, known or unknown, suspected or unsuspected, that Employee had, now has or may
hereafter claim to have against the Released Parties arising out of or relating in any way to Employee’s employment with, or termination from, the Company or otherwise relating to any of the Released Parties from the beginning of time to the
effective date of this Waiver and General Release of all Claims (the “Release”). This Release specifically extends to, without limitation, any and all claims or causes of action for wrongful termination, breach of an express or implied
contract, breach of the covenant of good faith and fair dealing, breach of fiduciary duty, fraud, misrepresentation, defamation, slander, infliction of emotional distress, disability, loss of future earnings, and any claims under any applicable
state, federal or local statutes and regulations, including, but not limited to, the Civil Rights Act of 1964, as amended, the Equal Pay Act of 1963, as amended, the Fair Labor Standards Act, as amended, the Americans with Disabilities Act of 1990,
as amended, the Rehabilitation Act of 1973, as amended, the Employee Retirement Income Security Act of 1974, as amended, the Worker Adjustment and Retraining Notification Act, as amended, Section 806 of the Sarbanes-Oxley Act, the Family and
Medical Leave Act, as amended, the California Family Rights Act, as amended, the California Fair Employment and Housing Act, as amended and California Labor Code Section 1400 et seq.; provided, however, that this Release does not waive,
release or otherwise discharge any claim or cause of action that cannot legally be waived, including, but not limited to, any claim for unpaid wages, workers’ compensation benefits, unemployment benefits and any claims under section 2802 of the
California Labor Code. 
 b. For the purpose of implementing a full and complete release, Employee understands and agrees that this
Agreement is intended to include all claims, if any, which Employee may have and which Employee does not now know or suspect to exist in his favor against the Released Parties and this Agreement extinguishes those claims. Accordingly, Employee
expressly waives all rights afforded by Section 1542 of the Civil Code of the State of California (“Section 1542”) and any other similar federal, state or local statute. Section 1542 states as follows: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE,
WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR. 

 2. ACKNOWLEDGMENTS. Employee agrees that prior to signing this Release, he read and understood each and
every provision of this Release and had the opportunity to consult with an attorney of his choosing regarding the effect of such Release. Employee further acknowledges and agrees that he knowingly and voluntarily executed this Release with complete
understanding of all relevant facts, and that he was neither fraudulently induced nor coerced to execute this Release. 
 3. MISCELLANEOUS. This
Release and all rights, duties and remedies hereunder shall be governed by and construed and enforced in accordance with the laws of the State of California, without reference to its choice of law rules. Employee agrees that this Release will be
binding upon, and pass to the benefit of, the successors and assigns of the Company and that this Release may not be amended or modified other than by a written instrument signed by the Company and Employee. 
  

			
		  	  
 David E. Snyder

		
		  	                          
 DateOffer Letter between Registrant and Caroline Dorsa

 Exhibit 10.58 
 October 4, 2007 
 Caroline Dorsa 
 Revised
Offer Letter 
 Dear Caroline, 
 Gilead Sciences, Inc. is
pleased to offer you the position of Chief Financial Officer reporting directly to me. We are very excited about the possibility of you joining Gilead in a key leadership role, and we look forward to the prospect of working with you. The following
outlines the specific terms of our offer: 
  

					
	 Base salary:
	  	$	500,000	 
	 Stock options:
	  	 	100,000	 
	 Sign-on bonus:
	  	$	250,000	 
	 Performance-based restricted shares:
	  	 	24,000	 
	 Target Bonus:
	  	 	40	%
	 Mortgage Subsidy:
	  	$	190,000	 

 Offer Details: 
  

	 	•	 	 Your salary on an annualized basis will be $500,000, less taxes, payable twice a month. 

  

	 	 •
	 	 The Compensation Committee of the Board of Directors has approved extending you an option to purchase 100,000 shares of
Gilead Sciences Common Stock. Your options will have an exercise price equal to the fair market value of Gilead common stock at the time of the option grant. Your options will be granted at the next Compensation Committee meeting following your date
of employment at Gilead. You will be notified of the details after the options have been granted. These options are subject to a five-year vesting provision; i.e., 20% of the total number of shares vest one year after the option grant date and the
remaining 80% vest in 5% installments every quarter in years two through five. Following this initial grant, you will be eligible to participate in Gilead’s stock option program under which you will be considered for annual grants based on your
performance. To be eligible for merit stock option grants for the performance year in which you are hired, you must be employed by June 30th.
Therefore, you will be eligible to participate in Gilead’s stock option program in Q’1 2009. 

  

	 	•	 	 You will be paid an employment bonus of $250,000, less taxes. This bonus will be reflected on your first payroll check subsequent to your start date at Gilead. In
the event that your employment terminates within two years of your start date, you will be required to repay all or a portion of this bonus to Gilead, provided, however, that no repayment shall be required if your termination is a
“Termination of Employment” described in Section IV(a)(i) of the Gilead Severance Plan (as amended and restated January 1, 2005)(the “Severance Plan”), which Severance Plan is incorporated by reference herein. In the event
of your voluntary termination, you will be required to repay this amount within 90 days of the termination date. 

  

	 	•	 	 Gilead will grant you an award of 24,000 shares of performance-based restricted common stock of Gilead pursuant to the 2004 Equity Incentive Plan. Three
vesting Milestones will be determined within the first 30 days of your employment. If fewer than all three vesting events occur before the fifth anniversary of your start date, any unvested restricted stock as of that date will be
forfeited. In addition, if you cease Continuous Active Service (as defined in the 2004 Equity Incentive Plan) for a reason other than death, disability (as defined in Section 22(e)(3) of the Internal Revenue Code) or a Change in Control
(as defined in the 2004 Equity Incentive Plan) before the date on which either of the three vesting events occurs or before the fifth anniversary of your start date, whichever is earlier, any unvested restricted stock as of the date your
Continuous Active Service ceases will be forfeited. You will be provided with a Restricted Stock Award Agreement which contains further details related to your restricted stock.

 Caroline Dorsa 
 October 4,
2007 
 Page 2 
 Within 30 days of the date of
grant, you may make a “Section 83(b) election” to include in gross income, for federal income tax purposes, an amount equal to the fair market value of the restricted stock on the date of grant.
  

	 	•	 	 You will be eligible to participate in an annual cash bonus program based on individual and company performance. Your target bonus is 40% of annual salary, less
taxes. The actual payout can range from 0% to 150% of this target, based on your performance against your annual goals and objectives, as well as the company’s overall performance. This bonus will not be prorated for 2007.

  

	 	•	 	 The Company will provide a mortgage subsidy to assist you when purchasing a home in a significantly higher cost housing area compared to your previous lower cost
housing area. The subsidy is an amount of money to be used only to help you purchase a home in the new location by reducing the mortgage’s interest rate for a period of time so that you can ease into the higher cost area. You cannot use the
mortgage subsidy for any purpose other than to reduce (temporarily) the interest rate on your loan. In order to be most tax advantageous to you, we will allow you to configure this subsidy in any manner you choose, provided it follows a reducing
schedule and all legal guidelines set forth by SIRVA mortgage. The mortgage subsidy is provided exclusively through SIRVA Mortgage for up to five years. The annual distribution is set on a reducing scale and the total subsidy amount is capped at
$190,000.00. If for any reason you are unable to take advantage of the full $190,000.00, the company will pay you the difference net, in the payroll cycle immediately following this event. 

  

	 	•	 	 You will receive $4000.00 net per month for up to six months, or until you current home sale is final, whichever comes first. 

  

	 	•	 	 We will provide you with up to 90 days of temporary accommodations in a fully furnished corporate apartment. Gilead and its relocation vendors will assist you with
the selection and billing for these accommodations. 

  

	 	•	 	 You will receive a moving allowance of up to $30,000 payable against receipts. This moving allowance is intended to relocate your household goods to California
utilizing the company-contracted carrier. If the moving costs are higher than provided for in this letter, approval for covering these additional costs will not be unreasonably withheld. 

  

	 	•	 	 Gilead will enroll you in their home marketing service, Buyer Value Option (BVO) Program, administered by our relocation vendor, SIRVA Relocation. All non-recurring
transaction costs in connection with the sale of your current home and purchase of a new home will be covered by Gilead, through SIRVA Relocation. This includes the real estate commission, typical seller closing costs, typical purchase closing
costs, and up to one mortgage “point” associated with the purchase of a new home. Please see the attached summary of our Relocation Program for further details. A complete policy will be provided to you by SIRVA Relocation.

  

	 	•	 	 You will be provided a lump sum of $20,000 (grossed up) for miscellaneous relocation expenses within the first week of your employment. This is intended to cover
items such as rental car, auto license and registration, lease termination and utility hook ups. If your miscellaneous expenses are higher than provided for in this letter, approval for covering these additional costs will not be unreasonably
withheld. Please retain all receipts for documentation of these expenses. 

  

	 	•	 	 Gilead Sciences will adjust certain relocation expenses to help offset the tax liability that may occur as a result of federal and state tax regulations. The
Company tax gross up will be based on your annualized base pay plus normal target incentive, or bonuses ONLY, excluding such one-time payments as stock options, deferred compensation, etc. Gilead Sciences will not include in its calculations any
income from any outside sources, like spousal or outside income. 

 Caroline Dorsa 
 October 4,
2007 
 Page 3 
  

	 	•	 	 The cash amount of this relocation package including, but not limited to, any moving allowance, temporary housing costs, transaction costs, and lump sums accepted
by you is due and payable to Gilead 90 days after your last date of employment if your employment should terminate for any reason within two years of your employment date, unless such termination is the result of a merger or acquisition of Gilead.

  

	 	•	 	 Gilead provides a comprehensive company-paid benefits package including health, dental, vision, life insurance, and long-term disability insurance plans. You are
eligible for health and welfare benefits if you are a full-time employee working 30 hours or more (unless otherwise specified). You will need to enroll for medical or dental/vision within 31 days of your hire date, or you will not be eligible to
enroll until the next open enrollment, unless you have a qualifying life event. Upon completion of enrollment, your coverage begins on your date of hire. 

  

	 	•	 	 For your information, we have enclosed a Benefits Summary outlining Gilead’s benefits programs. We will arrange for you to meet with a member of our
benefits staff to review your benefits package and enroll in the various programs. Please note that, as an executive, you will not accrue PTO but will instead have the flexibility of taking time off at your discretion in accordance with the
business needs of the corporation. 

  

	 	•	 	 At the next enrollment date, you will be eligible to participate in our Employee Stock Purchase Plan that offers you the opportunity to use up to 15% of your annual
salary, to the IRS maximum, through payroll deductions to purchase Gilead Common Stock at 85% of the market price at the date of enrollment or purchase. ESPP enrollment dates occur at the end of each quarter. Additionally, we offer a 401(k) plan,
which provides you with the opportunity for pre-tax long-term savings by deferring from 1-60% of your annual salary, subject to IRS maximums. Gilead will match 50% of up to 6% of your contributions to the plan. The maximum Company contribution is
$3,500 per year. More detailed information regarding your benefits will be provided at your New Employee Orientation, shortly after you begin employment. 

  

	 	•	 	 You will abide by Gilead Sciences’ strict company policy that prohibits any new employee from using or bringing with them from any prior employer any
proprietary information, trade secrets, proprietary materials or processes of such former employers. Upon starting employment with Gilead Sciences, you will be required to sign Gilead Sciences’ Confidentiality and Proprietary Inventions
Agreement for Employees indicating your agreement with this policy. 

  

	 	•	 	 You will also be required to sign the Employment Eligibility Verification (Form I-9). (You will need to complete and return section one of the I-9 Form along with
your signed offer letter). On your first day of employment, please bring the necessary documents that establish your identity and employment eligibility. 

  

	 	•	 	 You agree by signing below that the Company has made no other promises other than what is outlined in this letter. It contains the entire offer the Company is
making to you. Our agreement can only be modified by written agreement signed by you and the Company’s Representative. You also agree that should you accept a position at Gilead Sciences, the employment relationship is based on the mutual
consent of the employee and the Company. Accordingly, either you or the Company can terminate the employment relationship at will, at any time, with or without cause or advance notice. You should also note that the Company may modify wages and
benefits from time to time at its discretion. 

 This offer of employment is effective until October 12, 2007. The offer is also
contingent upon successful background and reference checks. There are two originals of this letter enclosed. 

 Caroline Dorsa 
 October 4,
2007 
 Page 4 
 If all of the foregoing is satisfactory, please
sign and date each original and return one to me by October 12, 2007 in the enclosed envelope, keeping the other original for yourself. Please also complete the following enclosed forms and mail them back with your signed offer letter:

  

	 	•	 	 I-9 Form 

  

	 	•	 	 W-4 Form 

  

	 	•	 	 Personal Data Sheet 

 Caroline, we look forward to
your joining the senior leadership team at Gilead Sciences. 
  

	
	Sincerely,
	
	/s/ John F. Milligan
	 John F. Milligan
 Chief Operating
Officer

 Foregoing terms and conditions hereby accepted: 
  

			
		
	Signed	 	/s/ Caroline Dorsa
	
	Date October 6, 2007
	
	Intended Start Date November 5, 2007

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}]]